ARHGAP31 and COVID-19: Activating-Rho GTPase-Activating Protein (ARHGAP31) was the major autoantigen identified in 22% of subjects with a prior SARS-CoV-2 infection and achieved enrichment with a 6-fold increase compared with the pre-COVID-19 controls [2].